Status:
UNKNOWN
Relationship Between Serum N/OFQ and Brain-heart Syndrome
Lead Sponsor:
Zheng Guo
Conditions:
Cerebral-Cardiac Syndrome
Eligibility:
All Genders
45-75 years
Brief Summary
Choosing the neurology patients in the Second Hospital of Shanxi Medical University, diagnosed with patients with cerebral syndrome into the experimental group; patients who did not have cerebral synd...
Eligibility Criteria
Inclusion
- Diagnostic criteria in compliance with cerebral syndrome
- Acute ischemic stroke patients in line with the "Chinese Acute Ischemic Stroke Treatment Guide 2018" related diagnostic criteria
- There is no intimate relationship between all selected people and knows this study, and signs informed consent
Exclusion
- Heart-type cerebral infarction, hemorrhagic stroke, brain tumor and past intracranial hemorrhage
- Complicated with severe cardiovascular complications (such as coronary heart disease, acute coronary syndrome, acute myocardial infarction, chronic heart failure, atrial fibrillation, etc.)
- Complicated with severe liver and kidney dysfunction (such as coagulous dysfunction, cirrhosis, nephrotic syndrome , Renal failure, etc.)
- Complicated with severe diabetes complications (such as diabetic nephropathy, diabetic foot, diabetic acidosis, high blood sugar hypertonic state, diabetes coronary heart disease, etc.)
- Complicated with Psychological disease
- Complicated with chronic obstructive pulmonary disease(COPD)
- BMI\> 40
Key Trial Info
Start Date :
May 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05344794
Start Date
May 1 2023
End Date
October 31 2023
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second of Shanxi Medical University
Taiyuan, Shanxi, China, 030001